{
    "clinical_study": {
        "@rank": "137879", 
        "arm_group": [
            {
                "arm_group_label": "e-Cigarette", 
                "arm_group_type": "Experimental", 
                "description": "STAM 1100mAh CE4 eGo Clearomizer e-Cigarette"
            }, 
            {
                "arm_group_label": "Nicotine polacrilex", 
                "arm_group_type": "Active Comparator", 
                "description": "Nicotine Replacement gum"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized trial comparing electronic cigarettes (e-Cigarettes) to nicotine gum\n      for smoking cessation. Participants will be randomly assigned to either e-cigarette use or\n      nicotine gum use during a quit attempt. All participants will have a one hour meeting with a\n      tobacco treatment specialist to develop a quit plan and set a quit date. Quit status will be\n      determined at 12 weeks after the quit date. Continued use of nicotine replacement (either\n      e-Cigarette or nicotine gum) and satisfaction with the treatment assignment will be\n      evaluated."
        }, 
        "brief_title": "e-Cigarettes Versus NRT Gum for Smoking Cessation", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Nicotine Addiction", 
            "Smoking Cessation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tobacco Use Disorder", 
                "Smoking", 
                "Behavior, Addictive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Smokes at least five cigarettes per day\n\n          -  No current or previous regular use of e-cigarettes\n\n          -  Ready to quit smoking\n\n        Exclusion Criteria:\n\n          -  Use of smokeless or pipe tobacco\n\n          -  Smoke more than 40 cigarettes per day\n\n          -  Pregnant or breastfeeding\n\n          -  Unable to chew gum due to dental or jaw problems\n\n          -  Myocardial infarction (heart attack) within the previous 12 months\n\n          -  Hypersensitivity to propylene glycol or nicotine gum"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01925781", 
            "org_study_id": "13-16684"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nicotine polacrilex", 
                "description": "2 mg and 4 mg gum will be used according to the FDA approved product labelling", 
                "intervention_name": "Nicotine polacrilex", 
                "intervention_type": "Drug", 
                "other_name": "Nicotine Gum"
            }, 
            {
                "arm_group_label": "e-Cigarette", 
                "intervention_name": "STAM 1100mAh CE4 eGo Clearomizer", 
                "intervention_type": "Other", 
                "other_name": [
                    "e-Cigarette", 
                    "electronic nicotine delivery device"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Smoking Cessation", 
            "Nicotine Addiction", 
            "e-Cigarette", 
            "electronic nicotine delivery device", 
            "electronic cigarette", 
            "nicotine replacement therapy"
        ], 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Omaha", 
                    "country": "United States", 
                    "state": "Nebraska", 
                    "zip": "68178"
                }, 
                "name": "Creighton University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation", 
        "other_outcome": [
            {
                "description": "Change in weight at 12 weeks after the quit date", 
                "measure": "Weight change", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Satisfaction with the assigned treatment will be assessed on a Likert scale", 
                "measure": "Satisfaction with the assigned treatment", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Creighton University", 
            "last_name": "Amy J Arouni, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "No smoking at 12 weeks after the predetermined quit date with a 5 day grace period. Self-report will be biochemically confirmed with expired carbon monoxide (CO) and salivary cotinine.", 
                "measure": "Sustained abstinence", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Continued use of nicotine in non-cigarette form (e-cigarette or gum) at 12 weeks after the quit date. Will be biochemical determined from salivary cotinine.", 
                "measure": "Continued use of nicotine replacement", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01925781"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "No smoking in the previous 7 days. Self report will be biochemically confirmed with expired CO and salivary cotinine.", 
            "measure": "Point prevalence abstinence", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "Creighton University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Creighton University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2014", 
        "why_stopped": "IND required"
    }
}